All Stories

  1. Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG

    Article • Proceedings of the National Academy of Sciences, October 2021, Proceedings of the National Academy of Sciences

    Herta Steinkellner

  2. Highly active engineered IgG3 antibodies against SARS-CoV-2

    Article • Proceedings of the National Academy of Sciences, October 2021, Proceedings of the National Academy of Sciences

    Herta Steinkellner

  3. Promoter Choice Impacts the Efficiency of Plant Glyco-Engineering

    Article • Biotechnology Journal, August 2017, Wiley

    Herta Steinkellner

  4. Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologue

    Article • Biotechnology Journal, November 2013, Wiley

    Herta Steinkellner